» Articles » PMID: 23205162

A Novel in Silico Approach to Identify Potential Therapeutic Targets in Human Bacterial Pathogens

Overview
Journal Hugo J
Publisher Springer
Specialty Genetics
Date 2012 Dec 4
PMID 23205162
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: In recent years, genome-sequencing projects of pathogens and humans have revolutionized microbial drug target identification. Of the several known genomic strategies, subtractive genomics has been successfully utilized for identifying microbial drug targets. The present work demonstrates a novel genomics approach in which codon adaptation index (CAI), a measure used to predict the translational efficiency of a gene based on synonymous codon usage, is coupled with subtractive genomics approach for mining potential drug targets. The strategy adopted is demonstrated using respiratory pathogens, namely, Streptococcus pneumoniae and Haemophilus influenzae as examples. Our approach identified 8 potent target genes (Streptococcus pneumoniae-2, H. influenzae-6), which are functionally significant and also play key role in host-pathogen interactions. This approach facilitates swift identification of potential drug targets, thereby enabling the search for new inhibitors. These results underscore the utility of CAI for enhanced in silico drug target identification.

Electronic Supplementary Material: The online version of this article (doi:10.1007/s11568-011-9152-7) contains supplementary material, which is available to authorized users.

Citing Articles

Structural and Functional Annotation and Molecular Docking Analysis of a Hypothetical Protein from : An In-Silico Approach.

Mazumder L, Rakibul Hasan M, Fatema K, Islam M, Tamanna S Biomed Res Int. 2022; 2022:4302625.

PMID: 36105928 PMC: 9467719. DOI: 10.1155/2022/4302625.


Pathogenomic in silico approach identifies NSP-A and Fe-IIISBP as possible drug targets in Neisseria Meningitidis MC58 and development of pharmacophores as novel therapeutic candidates.

Joshi M, Purohit M, Shah D, Patel D, Depani P, Moryani P Mol Divers. 2022; 27(3):1163-1184.

PMID: 35879631 DOI: 10.1007/s11030-022-10480-y.


Proteomic Characterization and Target Identification Against Streptococcus mutans Under Bacitracin Stress Conditions Using LC-MS and Subtractive Proteomics.

Zaidi S, Bhardwaj T, Somvanshi P, Khan A Protein J. 2022; 41(1):166-178.

PMID: 34989956 PMC: 8733428. DOI: 10.1007/s10930-021-10038-1.


Comparative proteomic analysis to annotate the structural and functional association of the hypothetical proteins of S. maltophilia k279a and predict potential T and B cell targets for vaccination.

Ezaj M, Haque M, Syed S, Khan M, Ahmed K, Khatun M PLoS One. 2021; 16(5):e0252295.

PMID: 34043709 PMC: 8159010. DOI: 10.1371/journal.pone.0252295.


Computational Identification of Essential Enzymes as Potential Drug Targets in Pathogenesis Using Metabolic Pathway Analysis and Epitope Mapping.

Narad P, Himanshu , Bansal H J Microbiol Biotechnol. 2020; 31(4):621-629.

PMID: 33323673 PMC: 9723279. DOI: 10.4014/jmb.2007.07006.


References
1.
Ikemura T . Codon usage and tRNA content in unicellular and multicellular organisms. Mol Biol Evol. 1985; 2(1):13-34. DOI: 10.1093/oxfordjournals.molbev.a040335. View

2.
Sakharkar K, Sakharkar M, Chow V . A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In Silico Biol. 2005; 4(3):355-60. View

3.
Rathi B, Sarangi A, Trivedi N . Genome subtraction for novel target definition in Salmonella typhi. Bioinformation. 2010; 4(4):143-50. PMC: 2825597. DOI: 10.6026/97320630004143. View

4.
Grosjean H, Fiers W . Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes. Gene. 1982; 18(3):199-209. DOI: 10.1016/0378-1119(82)90157-3. View

5.
Sharp P, Li W . The codon Adaptation Index--a measure of directional synonymous codon usage bias, and its potential applications. Nucleic Acids Res. 1987; 15(3):1281-95. PMC: 340524. DOI: 10.1093/nar/15.3.1281. View